Form 8-K - Current report:
SEC Accession No. 0001104659-25-097739
Filing Date
2025-10-08
Accepted
2025-10-08 08:00:40
Documents
46
Period of Report
2025-10-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2528131d1_8k.htm   iXBRL 8-K 29291
2 EXHIBIT 99.1 tm2528131d1_ex99-1.htm EX-99.1 33309
6 GRAPHIC tm2528131d1_ex99-1img001.jpg GRAPHIC 44097
7 GRAPHIC tm2528131d1_ex99-1img002.jpg GRAPHIC 15186
8 GRAPHIC tm2528131d1_ex99-1img003.jpg GRAPHIC 93953
9 GRAPHIC tm2528131d1_ex99-1img004.jpg GRAPHIC 79025
10 GRAPHIC tm2528131d1_ex99-1img005.jpg GRAPHIC 73170
11 GRAPHIC tm2528131d1_ex99-1img006.jpg GRAPHIC 102450
12 GRAPHIC tm2528131d1_ex99-1img007.jpg GRAPHIC 85495
13 GRAPHIC tm2528131d1_ex99-1img008.jpg GRAPHIC 94297
14 GRAPHIC tm2528131d1_ex99-1img009.jpg GRAPHIC 96386
15 GRAPHIC tm2528131d1_ex99-1img010.jpg GRAPHIC 123003
16 GRAPHIC tm2528131d1_ex99-1img011.jpg GRAPHIC 68722
17 GRAPHIC tm2528131d1_ex99-1img012.jpg GRAPHIC 37217
18 GRAPHIC tm2528131d1_ex99-1img013.jpg GRAPHIC 51184
19 GRAPHIC tm2528131d1_ex99-1img014.jpg GRAPHIC 86175
20 GRAPHIC tm2528131d1_ex99-1img015.jpg GRAPHIC 68508
21 GRAPHIC tm2528131d1_ex99-1img016.jpg GRAPHIC 160782
22 GRAPHIC tm2528131d1_ex99-1img017.jpg GRAPHIC 107393
23 GRAPHIC tm2528131d1_ex99-1img018.jpg GRAPHIC 122396
24 GRAPHIC tm2528131d1_ex99-1img019.jpg GRAPHIC 58348
25 GRAPHIC tm2528131d1_ex99-1img020.jpg GRAPHIC 92427
26 GRAPHIC tm2528131d1_ex99-1img021.jpg GRAPHIC 95000
27 GRAPHIC tm2528131d1_ex99-1img022.jpg GRAPHIC 137352
28 GRAPHIC tm2528131d1_ex99-1img023.jpg GRAPHIC 46568
29 GRAPHIC tm2528131d1_ex99-1img024.jpg GRAPHIC 52168
30 GRAPHIC tm2528131d1_ex99-1img025.jpg GRAPHIC 86002
31 GRAPHIC tm2528131d1_ex99-1img026.jpg GRAPHIC 86982
32 GRAPHIC tm2528131d1_ex99-1img027.jpg GRAPHIC 135945
33 GRAPHIC tm2528131d1_ex99-1img028.jpg GRAPHIC 85897
34 GRAPHIC tm2528131d1_ex99-1img029.jpg GRAPHIC 100124
35 GRAPHIC tm2528131d1_ex99-1img030.jpg GRAPHIC 87292
36 GRAPHIC tm2528131d1_ex99-1img031.jpg GRAPHIC 58241
37 GRAPHIC tm2528131d1_ex99-1img032.jpg GRAPHIC 56627
38 GRAPHIC tm2528131d1_ex99-1img033.jpg GRAPHIC 83108
  Complete submission text file 0001104659-25-097739.txt   3916382

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA syn-20251008.xsd EX-101.SCH 3041
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20251008_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20251008_pre.xml EX-101.PRE 22377
48 EXTRACTED XBRL INSTANCE DOCUMENT tm2528131d1_8k_htm.xml XML 3692
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 251381251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)